Cargando…

Targeting Regulatory T Cells for Therapy of Lupus Nephritis

Lupus glomerulonephritis (LN) is a complex autoimmune disease characterized by circulating autoantibodies, immune-complex deposition, immune dysregulation and defects in regulatory T cell (Tregs). Treatment options rely on general immunosuppressants and steroids that have serious side effects. Appro...

Descripción completa

Detalles Bibliográficos
Autores principales:	Venkatadri, Rajkumar, Sabapathy, Vikram, Dogan, Murat, Sharma, Rahul
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8775001/ https://www.ncbi.nlm.nih.gov/pubmed/35069220 http://dx.doi.org/10.3389/fphar.2021.806612

Ejemplares similares

The Yin and Yang of Alarmins in Regulation of Acute Kidney Injury
por: Sabapathy, Vikram, et al.
Publicado: (2020)

Targeting Bcl6 in the TREX1 D18N murine model ameliorates autoimmunity by modulating T‐follicular helper cells and germinal center B cells
por: Venkatadri, Rajkumar, et al.
Publicado: (2022)

Role of NLRP3 Inflammasome in Lupus Nephritis and Therapeutic Targeting by Phytochemicals
por: Wu, Dantong, et al.
Publicado: (2021)

Application of herbal traditional Chinese medicine in the treatment of lupus nephritis
por: Liu, Liu, et al.
Publicado: (2022)

Treatment for Severe Lupus Nephritis: A Cost-Effectiveness Analysis in China
por: Dai, Zonglin, et al.
Publicado: (2021)

Effect of Combined Mycophenolate and Rapamycin Treatment on Kidney Fibrosis in Murine Lupus Nephritis
por: Zhang, Chenzhu, et al.
Publicado: (2022)

Epoxyeicosatrienoic Acid Analog EET-A Blunts Development of Lupus Nephritis in Mice
por: Hye Khan, Md. Abdul, et al.
Publicado: (2019)

Novel Immunomodulatory Cytokine Regulates Inflammation, Diabetes, and Obesity to Protect From Diabetic Nephropathy
por: Sabapathy, Vikram, et al.
Publicado: (2019)

Molecular mechanism of Hedyotis Diffusae Herba in the treatment of lupus nephritis based on network pharmacology
por: Yang, Jinfei, et al.
Publicado: (2023)

Individualizing Therapy in Lupus Nephritis
por: An, Yu, et al.
Publicado: (2019)

Regulatory B and T Cells and Their Association With Clinical Response in New-Onset Lupus Nephritis Patients
por: Girimaji, Niveditha, et al.
Publicado: (2020)

Saponins from Panax notoginseng ameliorate steroid resistance in lupus nephritis through regulating lymphocyte-derived exosomes in mice
por: Chen, Jia, et al.
Publicado: (2022)

Lupus nephritis: The regulatory interplay between epigenetic and MicroRNAs
por: Xu, Ning, et al.
Publicado: (2022)

The Pathogenesis of Lupus Nephritis
por: Sterner, Rosalie M., et al.
Publicado: (2014)

Pediatric lupus nephritis
por: Pinheiro, Sergio Veloso Brant, et al.
Publicado: (2018)

Hyperhomocysteinemia and Lupus Nephritis
por: Timlin, Homa, et al.
Publicado: (2019)

Management of Lupus Nephritis
por: Tamirou, Farah, et al.
Publicado: (2021)

Lupus Nephritis and Dysbiosis
por: Monticolo, Marta, et al.
Publicado: (2023)

Peroxidasin Is a Novel Target of Autoantibodies in Lupus Nephritis
por: Manral, Pallavi, et al.
Publicado: (2019)

Non-histologic factors discriminating proliferative lupus nephritis from membranous lupus nephritis
por: Kwon, Oh Chan, et al.
Publicado: (2020)

The outcome of proliferative lupus nephritis with pulse cyclophosphamide therapy
por: Annavarajula, S. K., et al.
Publicado: (2011)

Eculizumab as rescue therapy in severe resistant lupus nephritis
por: Pickering, Matthew C., et al.
Publicado: (2015)

The history of pulse therapy in lupus nephritis (1976–2016)
por: Scheinberg, Morton
Publicado: (2016)

Expanding the Role of Complement Therapies: The Case for Lupus Nephritis
por: Li, Nicholas L., et al.
Publicado: (2021)

Zebra bodies in lupus nephritis after hydroxychloroquine therapy
por: Singh, Anshima, et al.
Publicado: (2023)

Kidney disease in lupus is not always 'lupus nephritis'
por: Anders, Hans-Joachim, et al.
Publicado: (2013)

Cytokine Overproduction, T-Cell Activation, and Defective T-Regulatory Functions Promote Nephritis in Systemic Lupus Erythematosus
por: Tucci, Marco, et al.
Publicado: (2010)

Value of Foxp3 expressing T-regulatory cells in renal tissue in lupus nephritis; an immunohistochemical study
por: Shakweer, Marwa M, et al.
Publicado: (2016)

Granulocyte colony-stimulating factor treatment ameliorates lupus nephritis through the expansion of regulatory T cells
por: Yan, Ji-Jing, et al.
Publicado: (2016)

Regulatory B Cell Therapy in Kidney Transplantation
por: Garcia, Sergio G., et al.
Publicado: (2021)

Renal Fibrosis in Lupus Nephritis
por: Sciascia, Savino, et al.
Publicado: (2022)

Lupus nephritis: current update
por: Saxena, Ramesh, et al.
Publicado: (2011)

The Role of Cytokine in the Lupus Nephritis
por: Iwata, Yasunori, et al.
Publicado: (2011)

Chapter 12: Lupus nephritis
Publicado: (2012)

Biomarker Profiling for Lupus Nephritis
por: Li, Yajuan, et al.
Publicado: (2013)

The Role of Autophagy in Lupus Nephritis
por: Wang, Linlin, et al.
Publicado: (2015)

Current status of lupus nephritis
por: Jaryal, Ajay, et al.
Publicado: (2017)

Antiphospholipid Antibodies in Lupus Nephritis
por: Parodis, Ioannis, et al.
Publicado: (2016)

Urinary biomarkers in lupus nephritis
por: Aragón, Cristian C., et al.
Publicado: (2020)

Podocyte Injury in Lupus Nephritis
por: Sakhi, Hamza, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_k3d1sbv7rale0j6go4gvrj9mun